| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized |
| Target | IFN-α |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6486H9990N1722O2026S44 |
| Molar mass | 145917.93 g·mol−1 |
| | |
Rontalizumab is ahumanizedmonoclonal antibody[1] being developed byGenentech.[2] As of November 2009[update], it is being investigated in aclinical trial for the treatment ofsystemic lupus erythematosus.[3][4]
Thismonoclonal antibody–related article is astub. You can help Wikipedia byexpanding it. |
Thisantineoplastic orimmunomodulatorydrug article is astub. You can help Wikipedia byexpanding it. |